0001628280-24-006982.txt : 20240226 0001628280-24-006982.hdr.sgml : 20240226 20240226193136 ACCESSION NUMBER: 0001628280-24-006982 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240222 FILED AS OF DATE: 20240226 DATE AS OF CHANGE: 20240226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pang Phillip CENTRAL INDEX KEY: 0001787370 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39083 FILM NUMBER: 24681312 MAIL ADDRESS: STREET 1: C/O VIR BIOTECHNOLOGY, INC. STREET 2: 499 ILLINOIS STREET, SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vir Biotechnology, Inc. CENTRAL INDEX KEY: 0001706431 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 812730369 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1800 OWENS STREET STREET 2: SUITE 900 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-906-4324 MAIL ADDRESS: STREET 1: 1800 OWENS STREET STREET 2: SUITE 900 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 wk-form4_1708993886.xml FORM 4 X0508 4 2024-02-22 0 0001706431 Vir Biotechnology, Inc. VIR 0001787370 Pang Phillip C/O VIR BIOTECHNOLOGY, INC. 1800 OWENS STREET, SUITE 900 SAN FRANCISCO CA 94158 0 1 0 0 EVP & Chief Medical Officer 1 Common Stock 2024-02-22 4 S 0 14568 10.0456 D 250111 D Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. /s/ Sung Lee, Attorney-in-Fact 2024-02-26